COVID-19

Survey responses indicated that almost 7 in 10 Americans are willing to get a COVID-19 vaccine when it becomes available.

After a temporary pause, investigators have received the green light to resume clinical trials for COVID-19 vaccine candidate AZD1222 following a safety review.

Here's this week's coronavirus-related news you should know.

In a partnership with top health care experts, MJH Life Sciences™ COVID-19 Coalition will host its inaugural event, "Battling Dual Threats: Flu and COVID-19 Converge" on Tuesday, September 15, at 6 p.m. EDT.

State-licensed pharmacists and pharmacy interns will be able to order and administer coronavirus disease 2019 vaccines under certain conditions.

Here's this week's coronavirus-related news.

AstraZeneca’s investigational coronavirus disease 2019 (COVID-19) vaccine candidate, AZD1222, has expanded into a phase 3 clinical trial.

A survey conducted by NCPA polled nearly 800 community pharmacy owners/managers on whether they plan to offer a COVID-19 vaccine in their pharmacies.

Here's the coronavirus-related news from this week that you should know.

Abbott’s BinaxNOW COVID-19 Ag Card rapid test produces results in 15 minutes.

ASHP issued its recommended principles for the development, distribution, allocation, and oversight of an eventual COVID-19 vaccine.

Individuals with metabolic syndrome who were hospitalized for COVID-19 were more likely to experience worse outcomes.

Here's this week's coronavirus-related news that you should know.

Caregivers of children with ADHD can choose from an increasing number of treatments that can be customized.

Oncology medical and infusion services have declined since the start of COVID-19.

Two senior administration officials from Operation Warp Speed offered the latest updates on COVID-19 vaccine development.

Walgreens has announced its commitment to getting ahead of an early and condensed flu season amid the COVID-19 pandemic.

Here's the coronavirus-related news from this week that you should know.

A Kawasaki-like inflammatory disease has affected children who have coronavirus disease 2019.

The pharmaceutical company increased production by more than 25% in the United States.

The Chinese Gastroenterology Expert Group and the Chinese Society of Gastroenterology published new management consensus for digestive disorders in patients with the coronavirus disease 2019.

The US government and Moderna are collaborating to produce 100 million doses of investigational COVID-19 vaccine candidate mRNA-1273.

Keep up-to-date on flu vaccine options and counseling considerations, especially as coronavirus disease 2019 continues to strike.

Experts worry that the approval is prioritizing the economy and national prestige over safety.

The COVID-19 crisis poses unique challenges for managing controlled substances in hospitals.

Here's this week's coronavirus-related news you should know.

Long-term care facilities will be the focus of Eli Lilly’s BLAZE-2 study for testing its LY-CoV555 antibody against SARS-CoV-2.

ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.

Three scientists discuss the global race for a COVID-19 vaccine.

The state joins New York and Minnesota in providing COVID-19 vaccination access through pharmacy.